What is the main reason for the amendment of CME Group's Bylaws?

The main reason for amending the Bylaws is to ensure compliance with the new SEC Universal Proxy Rules (Rule 14a-19) which aim to standardize proxy solicitations.

How will these Bylaw changes affect shareholders?

Shareholders intending to solicit proxies will need to provide evidence that they have complied with the requirements of the Universal Proxy Rules. The company also has established remedies should a shareholder fail to meet these requirements.

Are there any changes related to the election of directors?

Yes, the Amended Bylaws remove outdated references to Class B Nominating Committees, as this process concluded with the 2020 Annual Meeting. This simplifies the director election process by removing obsolete provisions.

Are there any other significant changes beyond Universal Proxy Rules and director nominations?

The filing mentions that certain other non-substantive and clarifying changes have been incorporated into the Amended Bylaws to enhance clarity and alignment with current practices.

CME 8-K: Corporate Changes

Summary

CME Group Inc. (CME) has filed an 8-K report detailing amendments to its Bylaws, effective December 7, 2022. These changes are primarily driven by the need to comply with new SEC Universal Proxy Rules (Rule 14a-19). The amendments introduce requirements for shareholders to provide evidence of compliance with these new solicitation rules and grant the company remedies in cases of non-compliance. Furthermore, the Amended Bylaws remove outdated references to Class B Nominating Committees for the election of Class B Directors, a process that concluded with the 2020 Annual Meeting. These updates aim to modernize corporate governance practices and ensure alignment with current regulatory requirements, which is a positive step for the company's governance structure and shareholder engagement.

Key Highlights

1CME Group Inc. adopted Amended and Restated Bylaws effective December 7, 2022.
2The primary driver for the amendment is compliance with SEC Universal Proxy Rules (Rule 14a-19).
3Shareholders will be required to provide evidence of compliance with the Universal Proxy Rules' solicitation requirements.
4The company has established remedies for shareholders failing to meet these new requirements.
5References to the obsolete Class B Nominating Committees have been removed from the Bylaws.
6These changes reflect an update to CME's corporate governance to align with regulatory changes and streamline board election processes.

CME GROUP INC. 8-K Report, Bylaw Amendment (Dec 9, 2022)

Summary

Key Highlights

Frequently Asked Questions